Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab

Br J Dermatol. 2020 Aug;183(2):404. doi: 10.1111/bjd.19137. Epub 2020 Jul 13.

Authors

A Harrer^{1

2}, R Lang¹, P Kölblinger¹

Affiliations

¹ Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria.
² Department of Neurology, Paracelsus Medical University, Salzburg, Austria.

PMID: 32319671
DOI: 10.1111/bjd.19137

No abstract available

Publication types

Letter
Comment

MeSH terms

Epitopes
Humans
Monitoring, Immunologic
Natalizumab

Substances

Epitopes
Natalizumab